Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rankning i aktier #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Aktiekurs
$12.33
Senast synkroniserad: 2026-08-31
Marknadsvärde
$428.31M
Förändring (1 dag)
0.49%
Förändring (1 år)
39.01%
Land
US
Handel Fennec Pharmaceuticals Inc. (FENC)

Kategori

Aktiekurshistorik för Fennec Pharmaceuticals Inc. (FENC)
Högsta slutkurs: $11.76 den 2026-08-01

Lägsta slutkurs: $11.52 den 2017-09-01
Aktiekurshistorik för Fennec Pharmaceuticals Inc. från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 11.99%
2025 25.75%
2024 -39.44%
2023 2.87%
2022 131.45%
2021 -44.21%
2020 23.34%
2019 -0.18%
2018 -33.41%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.88 -10.84%
AU
$138.80 476.17%
US
$749.90 5.10%
CH